Rheumatology: Current Research : Citations & Metrics Report
Articles published in Rheumatology: Current Research have been cited by esteemed scholars and scientists all around the world. Rheumatology: Current Research has got h-index 17, which means every article in Rheumatology: Current Research has got 17 average citations.
Following are the list of articles that have cited the articles published in Rheumatology: Current Research.
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Year wise published articles |
60 | 41 | 12 | 15 |
Year wise citations received |
138 | 104 | 90 | 88 |
Journal total citations count | 972 |
Journal impact factor | 2.82 |
Journal 5 years impact factor | 3.38 |
Journal cite score | 3.26 |
Journal h-index | 17 |
Journal h-index since 2019 | 12 |
Important citations (516)
Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases |
|
Successful nonoperative treatment of a lumbar spine extension injury with disruption of all three bony columns in a patient with ankylosing spondylitis – a case report |
|
Roles and responsibilities of a pharmacist for the patients in needa better therapy |
|
Evaluation of serum interleukin-6 (il-6), il-13, and il-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients. |
|
Multimodality imaging in connective tissue disease-related interstitial lung disease |
|
Assessment of transthoracic sonography in patients with interstitial lung diseases |
|
Automated 3d ?nterstitial lung disease ?xtent quantification: performance evaluation and correlation to pfts |
|
Incidental paratracheal air cysts on thoracic ct and their association with chronic inflammatory lung disease. |
|
Selecting registration schemes in case of interstitial lung disease follow-up in ct |
|
Pulmonary artery dimensions as a prognosticator of transplant-free survival in scleroderma interstitial lung disease |
|
Organizing pneumonia/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression. |
|
Measures of disease status in systemic sclerosis: a systematic review |
|
Development and validation of the scleroderma clinical trials consortium damage index (sctc-di): a novel instrument to quantify organ damage in systemic sclerosis |
|
Comparison of a new, modified lung ultrasonography technique with high-resolution ct in the diagnosis of the alveolo-interstitial syndrome of systemic scleroderma |
|
Interstitial lung disease in systemic sclerosis: diagnosis and management |
|
Pulmonary involvement in patients with systemic sclerosis |
|
Pulmonary involvement in scleroderma |
|
Functional evaluation of patients with progressive systemic sclerosis-associated diffuse parenchymal lung disease |
|
Imaging features of systemic sclerosis-associated interstitial lung disease |
|
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review |
|